% Expired Patents = 42.9

CIPO Patents = 2

EPO Patents = 1

Forward Citations = 48

Loading Chart...

5 inventors (with patents filed for the assignee):

Atul M Mehta (5 out of 22 patents)

Christopher C Dick (2 out of 2 patents)

David F Erkoboni (2 out of 12 patents)

4. Gary Bubb (2 out of 2 patents)

5. Charanjit R Behl (2 out of 10 patents)

6. Manish S Shah (26 patents)

7 patents: Sort by Forward Citations

1. 10213388 - Abuse resistant oral dosage forms (2019-02-26),

2. 9056054 - Abuse resistant oral dosage forms (2015-06-16),

3. 8703186 - Abuse-resistant oral dosage forms and method of use thereof (2014-04-22),

4. 8425933 - Abuse-resistant oral dosage forms and method of use thereof (2013-04-23),

5. 8182836 - Abuse-resistant oral dosage forms and method of use thereof (2012-05-22),

6. 6984402 - Chrono delivery formulations and method of treating atrial fibrillation (2006-01-10),

7. 6926909 - Chrono delivery formulations and method of use thereof (2005-08-09),

Company Overview

Elite Laboratories, Inc. is a leading pharmaceutical company that specializes in the development and manufacturing of generic and OTC medications. With state-of-the-art facilities and a team of experienced professionals, Elite Labs is committed to providing high-quality products to improve the health and well-being of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#10 in Northvale, NJ

#1,482 in New Jersey

#39,907 in US

Northvale, NJ, United States of America

Elite Laboratories, Inc.

Forward Citations = 48

5 inventors:

Atul M Mehta (5 out of 22 patents)

Christopher C Dick (2 out of 2 patents)

David F Erkoboni (2 out of 12 patents)

4. Gary Bubb (2 out of 2 patents)

5. Charanjit R Behl (2 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Elite Laboratories, Inc.. Retrieved from https://idiyas.com/company/elite-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]